Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
about
Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Downregulation of CSN6 attenua ...... cancer cells to FH535 therapy.
@en
Downregulation of CSN6 attenua ...... cancer cells to FH535 therapy.
@nl
type
label
Downregulation of CSN6 attenua ...... cancer cells to FH535 therapy.
@en
Downregulation of CSN6 attenua ...... cancer cells to FH535 therapy.
@nl
prefLabel
Downregulation of CSN6 attenua ...... cancer cells to FH535 therapy.
@en
Downregulation of CSN6 attenua ...... cancer cells to FH535 therapy.
@nl
P2093
P2860
P356
P1433
P1476
Downregulation of CSN6 attenua ...... cancer cells to FH535 therapy
@en
P2093
Rong-Liang Shi
Wen-Jun Wei
Yu-Long Wang
Zhong-Wu Lu
P2860
P304
P356
10.1002/CAM4.1272
P407
P50
P577
2018-01-17T00:00:00Z